Poor Control of Sarcoidosis-Related Panuveitis with an Antibody to IL-23

Click to increase image sizeClick to decrease image size

Additional information

Funding

AST and JTR are supported by an unrestricted institutional grant from Research to Prevent Blindness (New York, NY) and core grant P30 EY010572 from the National Institute of Health (Bethesda, MD). This work was supported NIH grant EY026572 and funds from the William and Mary Bauman Foundation and the Stan and Madelle Rosenfeld Family Trust. JTR is a consultant for Abbvie, UCB, Gilead, Roche, Janssen, Santen, Novartis. He receives research support from Pfizer. He receives royalties from UpToDate.